Status:

COMPLETED

Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke

Lead Sponsor:

Clinical Institute of the Brain, Russia

Collaborating Sponsors:

Institute of Medical Cells Technologies

City Hospital No 40, Saint Petersburg, Russia

Conditions:

Ischemic Stroke

Eligibility:

All Genders

40-70 years

Phase:

PHASE2

Brief Summary

The aim of the study is to investigate treatment with Leukostim (Filgrastim; granulocyte-colony stimulating factor; G-CSF) for acute ischemic stroke.

Detailed Description

Stroke is one of the main reasons of mortality and morbidity all over the world. In economically developed countries stroke takes 2 or 3 place in the structure of morbidity and mortality. In animal mo...

Eligibility Criteria

Inclusion

  • Age between 40 to 70 years old
  • CT/MRI confirmed ischemic stroke in carotid area during 48 hours after the onset of clinical signs
  • Level of conscious lower than 15 and higher than 8 points by the Glasgow Coma Scale
  • Acute extremity paresis lower than 4 points by Medical Research Consul scale

Exclusion

  • Premorbid dependency (modified Rankin Scale \> 0)
  • Intracerebral hemorrhage
  • Transitory ischemic attack
  • Patients with previous stroke
  • Any disorders, that can affect interpretation of results (e.g. psychiatric or movement disorders)
  • Hematological diseases
  • Coagulopathy
  • Malignancy
  • Pregnancy and lactation
  • Organ dysfunction that would preclude tests required for this study
  • Known allergic reaction to G-CSF or a component of G-CSF
  • Patients that have received a cytokine within the last 1 month or are currently receiving a cytokine treatment

Key Trial Info

Start Date :

June 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2009

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00901381

Start Date

June 1 2007

End Date

February 1 2009

Last Update

January 7 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinical Institute of the Brain

Yekaterinburg, Russia, 620026